InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,599.19
(
0.40%
)
US TECH 100
19,994.20
(
0.42%
)
Dow Jones
39,393.82
(
0.26%
)
Brent Oil
85.11
(
0.48%
)
Bitcoin
57,825.33
(
-0.33%
)
Post# of 252549
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4144
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: DewDiligence post# 248473

Monday, 08/07/2023 4:49:59 PM

Monday, August 07, 2023 4:49:59 PM

Post# of 252549

Enanta expects that its current cash, cash equivalents and marketable securities and its continuing portion of cash from future royalty revenue, should be sufficient to meet the anticipated cash requirements of its existing business and development programs into the second half of fiscal 2027.



Thank Dew for link to the ENTA earnings report. I won't have time to listen to the CC until later tonight. ENTA has plenty of cash so plenty of time to partner for EDP-235 and to push their RSV drugs EDP-938 and EDP-323 further into trials.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up